{
  "id": "breast-biomarker-insights",
  "type": "biomarker_analysis",
  "display_name": "Breast Cancer Biomarker Utilization",
  "description": "Analysis of biomarker testing patterns and provider variation in breast cancer",
  "patient_count": 1520,
  "summary": "Hormone receptor and HER2 testing compliance is high (96%), but genomic testing varies significantly by provider and site.",
  "created_date": "2023-04-20",
  "charts": [
    {
      "title": "Genomic Testing Utilization by Site",
      "chart_type": "bar",
      "data_source": "breast-biomarker-details.json"
    }
  ],
  "recommendations": [
    "Develop consistent guidelines for genomic testing in early-stage breast cancer",
    "Address disparities in genomic testing across practice sites",
    "Implement decision support tools in EMR for test selection"
  ]
} 